Concepedia

Keiko Okuda

KO

Statistics

Publications

36

Citations

2.9K

H-Index

24

Active since

1988

Affiliations

Dana-Farber Cancer Institute(Current)

Kyoto Prefectural University of Medicine

Harvard University

Hyogo Medical University

Kawasaki Medical School

Keiko Okuda is an author at Dana-Farber Cancer Institute specializing in life sciences, cell signaling, and signal transduction.

Publications per year

1988–2021

36

Publications

36

Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.

Tsukasa Oda, Conor Heaney, J.R. Hagopian et al. · Journal of Biological Chemistry · 1994 · 286 citations · Full text

, , +17

ARG tyrosine kinase activity is inhibited by STI571

Keiko Okuda, Ellen Weisberg, D. Gary Gilliland et al. · Blood · 2001 · 259 citations · Full text

, , +12

The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.

Martin Sattler, Ravi Salgia, Keiko Okuda et al. · PubMed · 1996 · 258 citations

, , +16

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase

Keiko Okuda, JS Sanghera, SL Pelech et al. · Blood · 1992 · 203 citations · Full text

, , +11

Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes

Shinsuke Tanabe, M. Heesen, Izumi Yoshizawa et al. · The Journal of Immunology · 1997 · 182 citations · Full text

, , +17

1–5 of 36